JPRN-jRCTs042210083进行中（未招募）2 期
A single-center, randomized, non-comparative study to explore the optimal EUS-FNB method for obtaining specimen for multiple-gene panel test in patients with pancreatic cancer
Sato Junya0 个研究点目标入组 75 人开始时间: 2021年10月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 <= 80age old（—）
- 性别
- All
入选标准
- •1)Patient with suspected pancreatic malignant tumor
- •Patient with no indication of radical resection
- •2)Patient <=80 years
- •3)Patient scheduled to have a genetic panel test using tumor tissue
- •4)Patient with performance status <=1 according to the ECOG standard.
- •5)Patient with no severe disorders in major organs
- •6)Written informed consent
排除标准
- •1) Patient with history of radiation therapy or chemotherapy for pancreatic cancer.
- •2) Patient with the regular use of antithrombotic drugs that cannot be suspended during EUS-FNB
- •3) Patient with mental disorder
- •4) Inappropriate patient for the study
研究者
相似试验
招募中
不适用
Verification of the effect of a short-term intensive rehabilitation for patients with early-stage Parkinson's disease.s diseaseParkinson's diseaseJPRN-UMIN000049425agasaki Kita Hospital40
进行中（未招募）
不适用
A single-center, randomized, single-blind study in parallel groups to evaluate the efficacy and safety of a new intravenous iron HES preparation as compared to intravenous iron dextran (Cosmofer) in anemic patientsAnemia in chronic kidney diseaseEUCTR2009-014351-72-ATSerumwerk Bernburg
进行中（未招募）
1 期
A single-center, randomized, single-blind study in parallel groups to evaluate the efficacy and safety of a new intravenous iron HES preparation as compared to intravenous iron dextran (Cosmofer®) in EPO (erythropoietin) naïve patients suffering from anemiaEUCTR2009-014351-72-SKSerumwerk Bernburg50
招募中
1 期
A single center study to characterise in-vivo slow release of DTPA tablet in humansCTRI/2010/091/001359Defence R&D Organisation8
进行中（未招募）
1 期
A Randomized, Observer-Blind, Single-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of Enzira 2005/2006 compared to Mutagrip 2005/2006 in Healthy 'Adults@ aged >18 to <60 years and in Healthy 'Older Adults' aged >60 yearsprophylaxis of influenzaEUCTR2005-003331-44-GBCSL Limited400